Shanghai Bao Pharma files HKEX next-day return disclosing share repurchase at HKD 3.99 million

• Shanghai Bao Pharmaceuticals repurchased 240,900 H shares on Sept. 3, 2026 for treasury.
• Paid HKD 16.15–HKD 17.12 a share; aggregate consideration HKD 3,991,416.
• Cancelled shares: 0.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shanghai Bao Pharmaceuticals Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260903-12319408), on September 03, 2026, and is solely responsible for the information contained therein.